Blog

The First Secret Asteroid Mission Won’t Be the Last

The First Secret Asteroid Mission Won’t Be the Last

For generations, Western space missions have largely occurred out in the open. We knew where they were going, why they were going there and what they planned to do. But the world is on the verge of a new era in which private interests override such openness, with big money potentially on the line.Sometime in the coming year, a spacecraft from AstroForge, an American asteroid-mining firm, may be launched on a mission to a rocky object near Earth’s orbit. If successful, it will be the first wholly commercial deep-space mission beyond the moon. AstroForge, however, is keeping its target asteroid…
Read More
Serious Medical Errors Rose After Private Equity Firms Bought Hospitals

Serious Medical Errors Rose After Private Equity Firms Bought Hospitals

The rate of serious medical complications increased in hospitals after they were purchased by private equity investment firms, according to a major study of the effects of such acquisitions on patient care in recent years.The study, published in JAMA on Tuesday, found that, in the three years after a private equity fund bought a hospital, adverse events including surgical infections and bed sores rose by 25 percent among Medicare patients when compared with similar hospitals that were not bought by such investors. The researchers reported a nearly 38 percent increase in central line infections, a dangerous kind of infection that…
Read More
Tesla Strike in Sweden Highlights a Culture Clash

Tesla Strike in Sweden Highlights a Culture Clash

The Tesla technicians who walked off their jobs in Sweden say they still support the mission of the American company and its headline-grabbing chief executive. But they also want Tesla to accept the Swedish way of doing business.They call it the Swedish Model, a way of life that has defined the country’s economy for decades. At its heart is cooperation between employers and employees to ensure that both sides benefit from a company’s profit.Instead, four technicians who walked off their jobs on Oct. 27 said, they have been subjected to what they described as a “typical U.S. model”: six-day workweeks,…
Read More
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

When Dr. Monica M. Bertagnolli moved into the director’s suite at the National Institutes of Health, she brought with her a single piece of art, a lithograph created by the granddaughter of a cancer patient she once treated. It depicts an abstract geometric female figure and the organs she lost to cancer. Its title: “We Are Not What You Have Taken: A Response to Cancer.”The image speaks to Dr. Bertagnolli, a cancer surgeon who previously led the National Cancer Institute and is a breast-cancer survivor herself.After being nominated by President Biden in the spring and winning Senate confirmation last month,…
Read More
This N.Y.U. Student Owns a  Million Crypto Mine. His Secret Is Out.

This N.Y.U. Student Owns a $6 Million Crypto Mine. His Secret Is Out.

Jerry Yu has the trappings of what the Chinese call second-generation rich. He boasts a Connecticut prep-school education. He lives in a Manhattan condominium bought for $8 million from Jeffrey R. Immelt, the former General Electric chief executive. And he is the majority owner of a Bitcoin mine in Texas, acquired last year for more than $6 million.Mr. Yu, a 23-year-old student at New York University, has also become — quite unintentionally — a case study in how Chinese nationals can move money from China to the United States without drawing the attention of authorities in either country.The Texas facility,…
Read More
Bristol Myers to Acquire the Drugmaker Karuna for  Billion

Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

Bristol Myers Squibb, the global pharmaceutical giant, said on Friday that it would acquire Karuna Therapeutics, which makes drugs to treat schizophrenia and Alzheimer’s, in an all-cash deal valued at $14 billion as it looks to strengthen its pipeline of neuroscience drugs.Bristol Myers said in a statement that it would pay $330 per share in cash, a premium of roughly 53 percent to Karuna’s share price on Thursday.An increasing prevalence of schizophrenia, driven in part by an aging population, has led to a push to make more drugs to treat it. The market for such therapies is estimated to grow…
Read More